Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
- Federal Prosecutors Launch Criminal Prove of Opioid Makers and Distributors. Wall Street Journal. November 26, 2019.
Federal prosecutors are using a criminal law more commonly used against drug dealers in probe of 6 major pharmaceutical company.
2) Johnson & Johnson $70 Million Verdict Upheld. Bloomberg. November 26, 2019.
A Pennsylvania appeals court upheld the $70 million verdict against Johnson & Johnson in a lawsuit involving the anti-psychotic drug, Risperdal. The court ruled that punitive damages may be available.
3) Judge Partly Vacates Convictions of Insys’ Founder and Executives. Reuters. November 26, 2019.
U.S. District Judge ruled the evidence prosecutors presented at trial did not support finding that Insys’ founder and executives intended for doctors to prescribe the drug, Subsys, to patients who did not need it.
4) Federal Government Alleges $1 Billion in Fraud Against Former Outcome Health Executives. Chicago Tribune. November 25, 2019.
The former CEO and other executives face 26 counts of criminal fraud for their alleged roles in a nearly $1 billion fraud scheme at the company.
5) Former MiMedx CEO and COO Charged with Accounting Fraud. AJC. November 27, 2019.
Both executives face securities fraud charges for allegedly engaging in a scheme to fraudulently inflate the company’s revenue.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. Click here to Subscribe.
